Cmt Research Foundation Inc is located in Atlanta, GA. The organization was established in 2018. According to its NTEE Classification (H50) the organization is classified as: Nerve, Muscle & Bone Diseases Research, under the broad grouping of Medical Research and related organizations. As of 06/2022, Cmt Research Foundation Inc employed 5 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cmt Research Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2020, Cmt Research Foundation Inc generated $1.7m in total revenue. This represents relatively stable growth, over the past 2 years the organization has increased revenue by an average of 5.0% each year. All expenses for the organization totaled $1.5m during the year ending 12/2020. You can explore the organizations financials more deeply in the financial statements section below.
Since 2020, Cmt Research Foundation Inc has awarded 21 individual grants totaling $1,798,675. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2020
Describe the Organization's Mission:
Part 3 - Line 1
TO FUND RESEARCH WHICH DELIVERS TREATMENTS AND CURES TO END CHARCOT-MARIE-TOOTH (CMT).
Describe the Organization's Program Activity:
Part 3 - Line 4a
SUPPORT THE MOST PROMISING AND EFFICIENT CHARCOT-MARIE-TOOTH RESEARCH AIMED ONLY TOWARD DRUG DELIVERY BY DEVELOPING STRATEGIC ALLIANCES WITH ACADEMIC AND INDUSTRY STAKEHOLDERS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Patrick Livney Founder & Chairman | OfficerTrustee | 2 | $0 |
Susan Ruediger Founder & Chief Mission Officer | OfficerTrustee | 40 | $155,808 |
Susan Canavari Secretary | OfficerTrustee | 1 | $0 |
Adam Kauffman Treasurer | OfficerTrustee | 1 | $0 |
Paul August Member | Trustee | 2 | $0 |
Cleary Simpson CEO | OfficerTrustee | 40 | $0 |
Statement of Revenue | |
---|---|
Total Revenue from Contributions, Gifts, Grants & Similar | $1,686,278 |
Investment income | $1,330 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,687,608 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $105,231 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $175,983 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $239,412 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $10,177 |
Payroll taxes | $31,119 |
Fees for services: Management | $0 |
Fees for services: Legal | $29,683 |
Fees for services: Accounting | $10,921 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $205,210 |
Advertising and promotion | $29,424 |
Office expenses | $23,505 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $4,814 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $2,321 |
All other expenses | $0 |
Total functional expenses | $1,482,324 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $554,814 |
Savings and temporary cash investments | $1,251,254 |
Pledges and grants receivable | $925,215 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $2,731,283 |
Accounts payable and accrued expenses | $5,810 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $5,810 |
Net assets without donor restrictions | $0 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Total liabilities and net assets/fund balances | $2,725,473 |
Over the last fiscal year, Cmt Research Foundation Inc has awarded $823,150 in support to 8 organizations.
Grant Recipient | Amount |
---|---|
ACURASTEM INC PURPOSE: Collaborative research agreement | $80,500 |
JACKSON LABORATORY PURPOSE: Collaborative research agreement | $190,287 |
UNIVERSITY OF MISSOURI PURPOSE: Collaborative research agreement | $50,000 |
GEORGIA TECH RESEARCH CORPORATION PURPOSE: Collaborative research agreement | $96,000 |
SHIFT PHARMACEUTICALS PURPOSE: Collaborative research agreement | $110,000 |
NATIONWIDE CHILDREN'S HOSPITAL PURPOSE: Collaborative research agreement | $159,693 |